Search Results - "Heile, Michael"

Identifying and meeting the challenges of insulin therapy in type 2 diabetes by Sorli, Christopher, Heile, Michael K

“…Type 2 diabetes mellitus (T2DM) is a chronic illness that requires clinical recognition and treatment of the dual pathophysiologic entities of altered glycemic…”
Get full text

Type 2 diabetes in the US managed care setting: the burden of disease and rationale for an oral glucagon-like peptide-1 receptor agonist by Dougherty, Tanya, Heile, Michael

“…Diabetes affects an estimated 34 million US adults, with type 2 diabetes (T2D) accounting for 90% to 95% of cases. The downstream consequences of uncontrolled…”
Get full text

Integrating advances in insulin into clinical practice: Effective utilization of insulin in patient management by Heile, Michael K, Reid, Timothy S

“…The management of a patient with type 2 diabetes mellitus (T2DM) is typically a long-term process characterized by evolving strategies to meet and maintain the…”
Get full text

Burden of Illness in Type 2 Diabetes Mellitus by Cannon, Anthony, Handelsman, Yehuda, Heile, Michael, Shannon, Michael

“…An estimated 30.2 million Americans have diabetes, and this number is expected to increase based on trends over recent decades and compounded by an aging U.S…”
Get full text

The evidence for oral semaglutide in type 2 diabetes from a managed care perspective by Heile, Michael, Taddei-Allen, Patty

Get full text

Automated Insulin Delivery: Easy Enough to Use in Primary Care? by Heile, Michael, Hollstegge, Betty, Broxterman, Laura, Cai, Albert, Close, Kelly

“…There are three automated insulin delivery devices on the U.S. market, two of which are currently approved by the U.S. Food and Drug Administration. These…”
Get full text

Health-Related Quality of Life Assessments with Once-Weekly Glucagon-Like Peptide-1 Receptor Agonists in Type 2 Diabetes Mellitus by Billings, Liana K, Handelsman, Yehuda, Heile, Michael, Schneider, Doron, Wyne, Kathleen

“…Type 2 diabetes (T2DM) is associated with significant impairment in health-related quality of life (HRQoL). A patient-centered collaborative approach is…”
Get full text

Divergence in Perceptions of Diabetes Control among Patients with T2DM and Health Care Professionals (HCPs) by BROD, MERYL, TOMASZEWSKI, KENNETH J., ALLEN, AMY, KRUGER, DAVIDA F., HEILE, MICHAEL K., MOCARSKI, MICHELLE, SCHIFFMAN, ALISA, HANDELSMAN, YEHUDA

“…Background: Sixty percent of patients with T2DM on basal insulin have an A1C ≥7%. This study aimed to understand patient and HCP views of “control,” as this…”
Get full text

Differences in Patient Perspectives of Type 2 Diabetes Management and Care by Current A1C by BROD, MERYL, TOMASZEWSKI, KENNETH J., ALLEN, AMY, KRUGER, DAVIDA F., HEILE, MICHAEL K., MOCARSKI, MICHELLE, SCHIFFMAN, ALISA, HANDELSMAN, YEHUDA

“…Background: This analysis aimed to understand differences in patient perspectives of their type 2 diabetes (T2DM) management and whether perspectives differed…”
Get full text

Cardiovascular Outcomes with Once-Weekly GLP-1 RAs: Clinical and Economic Implications by Heile, Michael, Wyne, Kathleen, Billings, Liana K, Cannon, Anthony, Handelsman, Yehuda, Shannon, Michael

“…Type 2 diabetes mellitus (T2DM) is associated with an increased risk of atherosclerotic cardiovascular (ASCVD) disease, which is the largest contributor to the…”
Get full text

Divergence in perceptions of diabetes control among patients with type 2 diabetes mellitus treated with basal insulin and health care professionals: results from the US Perceptions of Control by Allen, Amy, Kruger, Davida, Heile, Michael, Brod, Meryl, Schiffman, Alisa, Handelsman, Yehuda, Tomaszewski, Kenneth J, Mocarski, Michelle

“…Background: Approximately 60% of the patients with type 2 diabetes mellitus (T2DM) on basal insulin have an HbA1c >7%. This analysis of the US Perceptions of…”
Get full text

Divergence in perceptions of diabetes control among patients with type 2 diabetes mellitus treated with basal insulin and health care professionals: results from the US Perceptions of Control by Allen, Amy, Kruger, Davida, Heile, Michael, Brod, Meryl, Schiffman, Alisa, Handelsman, Yehuda, Tomaszewski, Kenneth J, Mocarski, Michelle

“…Background: Approximately 60% of the patients with type 2 diabetes mellitus (T2DM) on basal insulin have an HbA1c [greater than or equal to]7%. This analysis…”
Get full text

The evolution of insulin therapy in diabetes mellitus by Heile, Michael, Schneider, Doron

Get full text

Divergence in perceptions of diabetes control among patients with type 2 diabetes mellitus treated with basal insulin and health care professionals: results from the US Perceptions of Control (POC-US) study by Tomaszewski, Kenneth J, Allen, Amy, Mocarski, Michelle, Schiffman, Alisa, Kruger, Davida, Handelsman, Yehuda, Heile, Michael, Brod, Meryl

“…Approximately 60% of the patients with type 2 diabetes mellitus (T2DM) on basal insulin have an HbA1c ≥7%. This analysis of the US Perceptions of Control…”
Get full text